-
ViRexx Medical Corp. (TSX:VIR) (AMEX:REX), company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living....
-
New research has discovered that infection and natural exposure to the 1918 influenza virus made survivors immune to the disease for the remaining of their lives. Antibodies produced by cells isolated from these survivors served as an effective therapy to protect mice from the highly lethal 1918 infection. The study ...
-
LinkMed's (STO:LMED) portfolio company AbSorber recently received FDA approval in the U.S. for its patented transplantation test XM-ONE®. Now AbSorber has received further support for its transplantation test from a major clinical trial in which six well-reputed transplantation centers in the U.S. and Sweden participated....
-
ImmuneRegen® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), announced a collaborative relationship with the Biodesign Institute at Arizona State University (ASU), Tempe, Ariz., to evaluate the effectiveness of ImmuneRegen's Viprovex® in boosting the immune response when used as an adjuvant in conjunction with unique ...
-
Platelets - those tiny, unassuming cells that cause blood to clot and scabs to form when you cut yourself - play an important early role in promoting cerebral malaria, an often lethal complication that occurs mostly in children. Affecting as many as half a billion people in tropical and subtropical ...
-
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. Children's National will join more than 20 other medical institutions ...
